Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

1,373,096 1,426,271

Amortization 140,911 117,830

Interest income (92,523) (935,932)

(Gain) on sale of assets (8,554) --

(Increase) decrease in assets:

Accounts receivable, trade -

related parties (15,693,689) (4,062,388)

Accounts receivable, trade -

third parties 22,722 --

Other receivables 498,556 2,239,427

Other receivables - related

parties (526,327) (4,120,698)

Inventories 190,894 1,628,894

Employee advances (185,415) (49,889)

Prepaid expense 365,778 406,509

Increase (decrease) in liabilities:

Accounts payable 1,223,358 (648,583)

Advances from customers - related

parties 663,444 (67,035)

Wages and benefits payable (422,254) (289,033)

Other taxes payable 1,205,680 (40,345)

Other payables (67,118) (83,390)

Other payables - related parties 16,388 (299,389)

Net cash provided by operating

activities (1,119,756) 9,858,034

CASH FLOWS FROM INVESTING ACTIVITIES:

Repayment from (loans to) related

parties 2,133,222 (4,689,017)

Collections from loans to local

government 450,197 --

Acquisition of intangible asset
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc....llowedthepatentapplicationfor,itsnano-particleoral...ghlyefficientapproachtoincorporatepeptidesor,prote...eryofdrugs,otherwiseadministeredasinjections.NODte...nymacromoleculardrugssuchasinsulin,interferon,gro...
(Date:11/24/2009)...yefficacyendpointhasbeenmetforpatientswithadvanced...CITY,Nov.24/PRNewswire-FirstCall/-AEternaZentarisI...opharmaceuticalcompanyfocusedonendocrinetherapyand...ase2studywithitstargetedcytotoxicpeptideconjugate,...ecurrentendometrialcancer.Inapersonalizedhealthcar...
(Date:11/24/2009)...Italy,November24/PRNewswire/--HealthRoboticstodaya...thagroupofselected,investors.ThisrecentlyformedTor...oticsCanada,Inc.andwillmarket,install,andsupport,H...udesthe,revolutionaryproductofferingsi.v.STATION(T...c.willalsoprovideassistanceonan"asneeded,basis"toi...
(Date:11/23/2009)...ll. You can think of it as origami very high-tec...inois have developed a technique for fabricating t...tures from thin films by coupling photolithography...teractions. , The films, only a few microns thick...e with thicker pieces of the same material. , "Th...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Water droplets direct self-assembly process in thin-film materials 2
...rnia, Lawrence Berkeley National Laboratory, Pio...ed Innovations in Biomedi... the Cure, the global,leader in the movement to en...nts of the 2007 Komen Brinker Award for Scientific...merit., (Logo: http://www.newscom.com/cgi-bin/pr...
... Standards and Technology (NIST) has developed an ...operties of materialshow stiff or stretchy they ar... of a meter. The new tool can be a cost-effective ...erials such as composites or thin-film structures....tware and electronics to process data acquired by ...
...rmaceuticals,Inc. (Nasdaq: ARNA ) today announced...re appointed to its board of directors. Mr. Schnei...ndependent directors and bring,significant financi...ement,experience to Arena,s board of directors. Ar...dit Committee and Mr. Woods to its Corporate Gover...
Other Biology Technology:Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 2Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 3Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 4NIST imaging system maps nanomechanical properties 2Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 2Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 3
(Date:11/23/2009)...University of Alabama at Birmingham (UAB) research...ng medical conditions (co-morbidity) do not explai...ericans compared to Caucasians who also have colon... Cancer , a journal of the American Cancer Society...co-morbidity are independent predictors of poor su...
(Date:11/23/2009)...al in unprecedented detail how the ribosome intera...and guide them toward their destination in biologi...xible fitting (MDFF) to examine the interaction of...s. , The first study, in Proceedings of the Na... signaling between the ribosome and an elongation ...
(Date:11/23/2009)...iscoveries about the multiple health benefits of v...e nutrient, increased awareness of the huge number...rch and even led to an appreciation of it as "natu...ealth of your immune system to prevention of heart...min D is now seen as one of the most critical nutr...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3International Experts to Review State of the Art Thinking on Signal Detection and Data Mining 58680 1International Experts to Review State of the Art Thinking on Signal Detection and Data Mining 58680 2International Experts to Review State of the Art Thinking on Signal Detection and Data Mining 58680 3New Book Provides Alcoholics with Hope for Stable Long Term Craving Free Sobriety 58676 1New Book Provides Alcoholics with Hope for Stable Long Term Craving Free Sobriety 58676 2avVaa World Health Care Products Inc Announces Second DRTV Test Week 14317 1avVaa World Health Care Products Inc Announces Second DRTV Test Week 14317 2avVaa World Health Care Products Inc Announces Second DRTV Test Week 14317 3
... Award Recognizes Leadership in Technology and Inn...., March 4 Lockheed Martin (NYSE: LMT ) has bee... of the Year" by Frost and Sullivan, recognizing t...ve biometrics solutions for a wide range of custom...ous analysis of the worldwide biometrics marketpla...
... , COLLEGE PARK, Md. There,s no "silver bullet" f... and acquisition policies, but they do need reform...fessor Jacques Gansler, who testified today before...directed the Defense Department,s acquisition oper...rved as a consultant for the Pentagon in interveni...
... Research into RNA, a molecule found in every cel... in the treatment of diseases such as cancer and d...ce Foundation was told. , The conference, held th...yra", CSIC in Granada, Spain, on 23 February 2009,...nt strategy for RNA research in Europe in recognit...
Other Biology News:Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan 2Reforming defense department acquisition policy: UM expert 2RNA research strategy for Europe takes shape 2
5' RACE Abridged Anchor Primer from Invitrogen
His-Patch ThioFusion Expression System from Invitrogen
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Mouse Anti-Human WDR5 Monoclonal Antibody, Unconjugated, Clone 2C2 from Abnova Corporation
Biology Products: